Chapter 22 Flashcards

1
Q

Hemostasis

A

The stoppage of blood flow where fibrin strands glue the aggregated platelets together to form blood clot —> plasma becomes gel like and traps RBCs and formed elements in blood

regulated by activators and inhibitors to prevent blood from leaving the vascular compartment

Normal when it seals a blood vessel to prevent blood loss and hemorrhage and abnormal when it causes inappropriate blood clotting or when clotting is insufficient to stop blood from from the vascular compartments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mechanisms of hemostasis

A

Vascular constriction, formation of the platelet plug, blood coagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What initiates vessel spasm?

A

Endothelial injury or local and humoral mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What factors contribute to vasoconstriction in blood coagulation/ hemostasis?

A

Neural reflexes and thromboxane A2, prostaglandin released from platelets

Most powerful: endothelial 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is used to seal small breaks in a vessel wall?

A

Platelet plugs, rather than blood clots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Platelets originate from

A

Thrombocytes or platelets arise from megakaryocytes

Eliminated by macrophages after 8-12 pages

Normal concentration: 150000-400000 platelets per microliter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Thrombopoeitin

A

Control protein production

Causes proliferation and maturation of magakaryocytes

Source: liver, kidneys, smooth muscle, bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Platelet granules

A

Release mediators for hemostasis

Types: alpha (vwb factors) and delta granules (adp and atp, ionize histamine, serotonin, vasoconstriction molecules)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Platelet plug formation

A

Activation, adhesion, and aggregation of platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Platelet activation

A

Platelets attracted to damaged vessel wall —> activated —> change from smooth disks to spiny spheres (expose glycoprotein receptors) —> platelet receptor binds to vWF at the injury site —> platelet and exposed collagen fibers are linked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

vWF

A

Required for platelet adhesion

leaks into injured tissue from plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Platelet aggregation

A

Combine actions of ADP and TXA2 lead to expansion of the enlarging platelet aggregate —> becomes primary hemostasis plug

Coagulation pathway activated on platelet surface —> fibrinogen is converted to fibrin —> fibrin mesh work that cements platelets and other blood components together —> p selection binds leukocytes to heal vessel wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What role does the platelet membrane play in the adhesion and coagulation process?

A

Glycoproteins: controls interactions with the vessel endothelium

Platelets interact with injured areas of the vessel wall and deeper exposed collagen

Glycoproteins receptors on membrane bind fibrinogen and link platelets together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Symptoms of defective platelet plug formation

A

Bleeding in people who are deficient in platelets or vWF

Usually superficial and localized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do platelets play a role in marinating normal vascular integrity?

A

By supplying growth factors for endothelial and arterial smooth muscle cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Platelet inhibitors

A

Pharmacological agents that work in different are of the adhesion-activation-aggregation progression

Eg: cyclooxygenase-1 (cox-1) like aspiring prevent clot formation in people who are at risk for MI, stroke, or peripheral artery disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What does low dose aspirin therapy do to vascular pathophysiology?

A

Inhibits prostaglandin synthesis (TXA2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Blood coagulation cascade

A

Converts soluble plasma protein, fibrinogen, into fibrin

Insolvable fibrin strands create a mesh work that cements platelets and other blood components together to form the clot

Results form the activation of the intrinsic and extrinsic pathways who form prothrombin activators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What regulate the coagulation process?

A

Procoagulation factors or anti coagulation factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How does vitamin K play a role in the coagulation process?

A

Necessary for the synthesis of factors II, VII, IX, and X in the cascade, as well as prothrombin, and protein C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Why does a bleeding tendency develop when a person is low on vitamin K?

A

There is not enough prothrombin created

Typically due to deficiency or liver failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Where is calcium involved in the coagulation cascade?

A

AKA factor IV

Required in all but the first two steps

Inactivation of calcium prevents blood from clotting when removed from the blood

23
Q

Intrinsic pathway

A

Slow process, clotting in 1-6 minutes

Termination: activation of factor X and conversion of prothrombin to thrombin

Activated: blood passes out of vascular system and comes into contact with collagen in injured vessel wall

Defects: lead to severe bleeding

24
Q

Extrinsic pathway

A

Faster process, clotting in 15 seconds

Begins with trauma to the BV or surrounding tissues

Termination: activation of factor X and conversion of prothrombin to thrombin

Activation: blood passes out of the vascular system and exposed to tissue extracts

Defects: bleeding is much less severe

25
Q

Action of thrombin

A

Acts as an enzyme to convert fibrinogen to fibrin (material that stabilizes a clot)

26
Q

What regulates blood coagulation?

A

Natural anticoagulants
Antithrombin III
Heparin

Provides protection against uncontrolled thrombus formation on the endothelial surface

27
Q

Protein C

A

Anticoagulation that inactivated factors V and VIII

28
Q

Protein S

A

Accolade rates action of protein C

A deficiency in protein C or protein S puts one at risk for thrombosis

29
Q

what are anticoagulant drugs used for?

A

warfarin and heparin

Prevent thromboembolic disorder

30
Q

Clot retraction

A

20-60 minutes after a clot has formed

Squeezes serum from clot and joins edges of broken vessel

Platelets are also involved

31
Q

What might cause a failure of clot retraction?

A

Low platelet count

32
Q

Clot dissolution

A

Begins shortly after blot clot formation to ensure blood flow can be reestablished and permanent tissue repair to take place

Plasminogen is activated into pals in —> digests fibrin strands of the clot and clotting factors —> limits fibrinolytic process to the local clot/ prevents from occurring in entire circulation

33
Q

Fibrinolysis

A

Process by which a blood clot dissolves

34
Q

Why would plasminogen activators be released?

A

In response to vasoactive drugs, venous occlusion, elevated body temperature, and exercise

35
Q

why does liver disease cause altered fibrinolytic activity?

A

Plasminogen actions are unstable and rapidly inactivated by inhibitors synthesized by the endothelium and the liver

36
Q

In high doses, what negative clinical implicates does plasminogen activator inhibitor 1 have?

A

Associates with DVT, coronary artery disease, and MI

37
Q

Hyper-coagulability States

A

Exaggerated form of hemostasis that predisposes thrombosis and blood vessel occlusion

Two forms: condition that create increased platelet function and conditions that cause accelerated activity of the coagulation system

38
Q

What conditions are associated with increased platelet function?

A
Atherosclerosis
Diabetes mellitus
Smoking
Elevated blood lipid and cholesterol levels
Increased platelet levels
39
Q

What condition are associated with accelerated activity of the clotting system?

A
Pregnancy and the puerperal
Use of oral contraceptives
Post surgical state
Immobility
Congestive heart failure
Malignant disease
40
Q

Pathophysiology of hypercoagulability associated with increased platelet function

A

Results in platelet adhesion, formation of platelet clots, and disruption fo blood flow

Eg: atherosclerotic plaques disturb blood flow —> endothelial damage —> prompt platelet adherence through growth factors —> proliferation of smooth muscle —> development of atherosclerosis

41
Q

Pathophysiology of hypercoagulability associated with increased clotting activity

A

Can result from primary (genetic) or secondary (acquired) disorders affecting coagulation components

42
Q

Thrombocytosis

A

Elevations in platelet count above 1,000,000 uL

Can be primary or secondary (caused by disease that stimulates thrombopoietin)

Clinical manifestation: thrombosis (portal and hepatic veins) and hemorrhage, DVT, PE

43
Q

Hereditary thrombopoeitin

A

Causes activated protein C resistance

Clinical manifestations: VTE (DVT and PE)

44
Q

What is a common cause of venous thrombosis in the immobilized or post surgical person?

A

Slow and disturbed flow that causes accumulation of activated clotting factors and platelet that are prevented from interacting with inhibitors

45
Q

Antiphospholipid syndrome

A

Cause of increased venous and arterial thrombosis

Associated with autoantibodies (igG) —> increased coagulation activity

Clinical manifestations: venous and arterial thrombi, recurrent fetal loss, thrombocytopenia

Can be primary or secondary

46
Q

Antiphospholipid syndrome treatment

A

Removal or reduction in factors that predispose to thrombosis, including advice to stop smoking and counseling against use of estrogen-containing oral contraceptive by women

Aspiring and anticoagulants and vitamin K anticoagulation’s may be used to prevent future thrombosis

47
Q

Consequence of bleeding disorders

A

Can result from defects in any of the factors that contribute to hemostasis

Eg: disorders associated with platelet number or function, coagulation factors, and blood vessel integrity

48
Q

Bleeding associated with platelet disorders

A

Due to decrease in platelet number due to decreased production, increased destruction, or impaired function of platelets

Petechiae is often seen in conditions of platelet deficiency, not dysfunction

49
Q

Thrombocytopenia

A

A reduction in platelet number often as a result of decreased platelet production, increased sequestration of platelets in the spleen, or decreased platelet survival; cause of generalized bleeding

Level less than 150,000 uL

50
Q

In what conditions is the decreased platelet production due to loss of bone marrow function?

A

Aplastic anemia

51
Q

Excessive pooling of platelets in the spleen

A

Splenomegaly; instead of sequestering 30-40 percent of platelets, the spleen holds onto way more, up to 90 percent

Leads to an enlarged spleen

52
Q

Drug-induced thrombocytopenia

A

Eg; aspiring, Astor a statin, antibiotics

Formation of immune complexes and induction of antigen-antibody response cause platelet destruction by complement-mediated lysis

53
Q

Heparin-induced thrombocytopenia (HIT)

A

Caused by an immune reaction against a complex of heparin and platelet factor 4

Activate remaining platelets leading to thrombosis

Promotion of coagulation

Treatment: immediate discontinuation of heparin

54
Q

Immune Thrombocytopenic Purpura

A

Platelet antibody formation and excess destruction of platelets

Primary ITP: autoimmune disease

Secondary forms of ITP: hemorrhagic symptoms might be absent

Platelet counts <20000 to 30000